Rare Disease Therapeutics

ANAVIP

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Rare Disease Therapeutics

Anavip HCPCS:

J0841

HCPCS Code Descriptor:

Injection, crotalidae immune f(ab')2 (equine), 120 mg

Category:

J Code

Anavip NDCs:

66621-0790-02

Primary Type:

Antivenin

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Anavip CPT Codes:

Potential CPT administration codes for Anavip can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Anavip:

ANAVIP is an Antivenin drug manufactured by Rare Disease Therapeutics and administered via the Intravenous route of administration. The J Code: J0841 is aligned to the drug ANAVIP.

ACCESS PRICING AND MORE BY REGISTERING

J0841 Added Date:

January 1, 2019

J0841 Effective Date:

January 1, 2019

J0841 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Anavip billing and coding information.
Our team did not identify a source for Anavip patient assistance information. Please reach out to our team if you feel that this is a mistake.
ANAVIP prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for ANAVIP. Please check back in a few weeks.